Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Arcus Biosciences, Inc.”

30 pharma patents match "Arcus Biosciences, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 30
Index total 30,257
Page 2 / 2

Quick answer

This filtered view shows 30 pharmaceutical patents matching "Arcus Biosciences, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

30 results for “Arcus Biosciences, Inc.” · 30,257 patents in full index Clear search

  1. US 11058704

    Inhibitors of adenosine 5′-nucleotidase

    Arcus Biosciences, Inc. · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  2. US 11045472

    Quinazoline-pyridine derivatives for the treatment of cancer-related disorders

    Arcus Biosciences, Inc. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  3. US 11001603

    Modulators of 5′-nucleotidase, ecto and the use thereof

    Arcus Biosciences, Inc. · Granted May 11, 2021 · Expires May 6, 2041

    granted
  4. US 10981944

    Modulators of 5′-nucleotidase, ecto and the use thereof

    Arcus Biosciences, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  5. US 10399962

    Azolopyrimidine for the treatment of cancer-related disorders

    Arcus Biosciences, Inc. · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted
  6. US 10239912

    Modulators of 5′-nucleotidase, ecto and the use thereof

    Arcus Biosciences, Inc. · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted